. 2022 Mar 4;55(10):1330–1341. doi: 10.1111/apt.16820
© 2022 The Authors. Alimentary Pharmacology & Therapeutics published by John Wiley & Sons Ltd.
This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
FIGURE 1.
Rate of ADM initiation by drug type following IBD diagnosis